Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)CHAREHBILI, A; VAN DE VEN, S; PEPELS, M. J et al.Annals of oncology. 2014, Vol 25, Num 5, pp 998-1004, issn 0923-7534, 7 p.Article

Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian CancerODUNSI, Kunle; MATSUZAKI, Junko; BECK, Amy et al.Cancer immunology research (Print). 2014, Vol 2, Num 1, pp 37-49, issn 2326-6066, 13 p.Article

Survival Prediction in Everolimus-treated Patients with Metastatic Renal Cell Carcinoma Incorporating Tumor Burden Response in the RECORD-1 TrialSTEIN, Andrew; BELLMUNT, Joaquim; ESCUDIER, Bernard et al.European urology. 2013, Vol 64, Num 6, pp 994-1002, issn 0302-2838, 9 p.Article

The in situ local immune response, tumour senescence and proliferation in colorectal cancerROXBURGH, C. S; RICHARDS, C. H; MACDONALD, A. I et al.British journal of cancer. 2013, Vol 109, Num 8, pp 2207-2216, issn 0007-0920, 10 p.Article

Évaluation de la qualité des comptes rendus radiologiques des examens tomodensitométriques d'évaluation oncologique = Quality assessment of radiologic reports of CT examinations for tumor response evaluationJUNGMANN, Sven; KARA, Mona; MONNIER-CHOLLEY, Laurence et al.Bulletin du cancer. 2014, Vol 101, Num 6, pp 554-557, issn 0007-4551, 4 p.Article

Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abirateroneLORENTE, D; OMLIN, A; DEARNALEY, D et al.British journal of cancer. 2014, Vol 111, Num 12, pp 2248-2253, issn 0007-0920, 6 p.Article

Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapyMARINOVICH, M. L; MACASKILL, P; IRWIG, L et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1528-1536, issn 0007-0920, 9 p.Article

Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancerJONES, Robert; VUKY, Jacqueline; GSCHWEND, Jürgen E et al.Investigational new drugs. 2013, Vol 31, Num 4, pp 1001-1007, issn 0167-6997, 7 p.Article

Quantified Pathologic Response Assessed as Residual Tumor Burden Is a Predictor of Recurrence-Free Survival in Patients With Rectal Cancer Who Undergo Resection After Neoadjuvant ChemoradiotherapyAGARWAL, Atin; CHANG, George J; RODRIGUEZ-BIGAS, Miguel et al.Cancer. 2013, Vol 119, Num 24, pp 4231-4241, issn 0008-543X, 11 p.Article

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapyTAZZARI, M; NEGRI, T; STACCHIOTTI, S et al.British journal of cancer. 2014, Vol 111, Num 7, pp 1350-1362, issn 0007-0920, 13 p.Article

Comparison of performance of various tumour response criteria in assessment of regorafenib activity in advanced gastrointestinal stromal tumours after failure of imatinib and sunitinibSHINAGARE, Atul B; JAGANNATHAN, Jyothi P; KURRA, Vikram et al.European journal of cancer (1990). 2014, Vol 50, Num 5, pp 981-986, issn 0959-8049, 6 p.Article

Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical TrialsBRUNO, R; MERCIER, F; CLARET, L et al.Clinical pharmacology and therapeutics. 2014, Vol 95, Num 4, pp 386-393, issn 0009-9236, 8 p.Article

Réponse tumorale et biothérapie: quelles nouveautés ? = Tumoral response and biotherapy: what's new?DROMAIN, C.La Lettre du cancérologue (Boulogne). 2014, Vol 23, Num 5, pp 160-163, issn 1165-113X, 4 p.Conference Paper

Multicenter Validation Study of Pathologic Response and Tumor Thickness at the Tumor-Normal Liver Interface as Independent Predictors of Disease-Free Survival After Preoperative Chemotherapy and Surgery for Colorectal Liver MetastasesBROUQUET, Antoine; ZIMMITTI, Giuseppe; GANDINI, Alessandro et al.Cancer. 2013, Vol 119, Num 15, pp 2778-2788, issn 0008-543X, 11 p.Article

Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and RhabdomyolysisLE MIN; HODI, F. Stephen.Cancer immunology research (Print). 2014, Vol 2, Num 1, pp 15-18, issn 2326-6066, 4 p.Article

Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabinePAPADEMETRIO, Daniela Laura; CAVALIERE, Victoria; SIMUNOVICH, Tania et al.Targeted oncology. 2014, Vol 9, Num 2, pp 123-134, issn 1776-2596, 12 p.Article

La réduction des volumes ou l'intensité de la réponse tumorale en cancérologie colorectale = The Reduction in Volume or Intensity of Tumour Response in Colorectal OncologyPHELIP, J.-M; BOUARIOUA, N; TATU, A et al.Oncologie (Paris). 2014, Vol 16, Num 11-12, pp 587-592, issn 1292-3818, 6 p.Article

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRIBELOUECHE-BABARI, M; JAMIN, Y; LEACH, M. O et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1562-1569, issn 0007-0920, 8 p.Article

Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatmentNEL, I; GAULER, T. C; EBERHARDT, W. E et al.British journal of cancer. 2013, Vol 109, Num 5, pp 1223-1229, issn 0007-0920, 7 p.Article

Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: Balancing cancer and tissue renewal impairmentHARTWIG, Fernando Pires; COLLARES, Tiago.Ageing research reviews. 2013, Vol 12, Num 2, pp 642-652, issn 1568-1637, 11 p.Article

Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted TherapySMITH, Neil R; BAKER, Dawn; WEDGE, Stephen R et al.Clinical cancer research (Print). 2013, Vol 19, Num 24, pp 6943-6956, issn 1078-0432, 14 p.Article

Imagerie fonctionnelle de la réponse aux thérapies ciblées: TDM et IRM = Functional imaging of treatment response: CT and MRIFOURNIER, L. S; AMMARI, S; THIAM, R et al.Correspondances en onco-urologie. 2013, Vol 4, Num 3, pp 106-109, issn 2110-087X, 4 p.Article

FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K-AKT PathwayAIFU LIN; PIAO, Hai-Long; LI ZHUANG et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 6, pp 1682-1693, issn 0008-5472, 12 p.Article

Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugatesWADA, Russ; ERICKSON, Hans K; LEWIS PHILLIPS, Gail D et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 969-980, issn 0344-5704, 12 p.Article

Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate ProcessingRUGHETTI, Aurelia; RAHIMI, Hassan; BURCHELL, Joy M et al.Cancer immunology research (Print). 2014, Vol 2, Num 2, pp 177-186, issn 2326-6066, 10 p.Article